论文部分内容阅读
目的 探讨 QRS记分 ( QRSS)评估急性心肌梗死 ( AMI) ,早期溶栓治疗效果的价值。方法 选择符合 WHO AMI诊断标准的患者 6 7例 ,其中无溶栓适应证未溶栓 (无溶栓组 )者 2 1例 ,有溶栓适应证 (溶栓组 )者 46例 ,给予尿激酶 15 0万 U溶栓治疗 ,记录全部患者常规 12导联 ECG并作 QRSS比较。结果 溶栓再通组 2 5例 ,QRSS 1.9± 1.8,QRSS≤ 3分 19例 ( 76 %) ,溶栓未通组2 1例 ,QRSS4.0± 1.4,QRSS≤ 3分 5例 ( 2 3.8%) ,无溶栓组 2 1例 ,QRSS5 .0± 1.9,三组比较均有显著性差异。结论 AMI早期进行溶栓治疗可减少 QRSS,QRSS可作为判断早期溶栓血管再通的参考。
Objective To investigate the value of QRS score (QRSS) in evaluating acute myocardial infarction (AMI) and early thrombolytic therapy. Methods Totally 67 patients were selected according to the diagnostic criteria of WHO AMI. Among them, 21 without thrombolytic therapy (no thrombolytic therapy) and 46 with thrombolytic therapy (thrombolytic therapy) were given urokinase 1500000 U thrombolytic therapy, recording all patients conventional 12-lead ECG and QRSS comparison. Results In the thrombolytic group, 25 cases were QRSS 1.9 ± 1.8, QRSS≤3 points in 19 cases (76%), thrombolysis in 21 cases, QRSS4.0 ± 1.4, QRSS≤3 in 5 cases (2 3.8 %), No thrombolysis group 21 cases, QRSS5.0 ± 1.9, the three groups were significantly different. Conclusions Early thrombolytic therapy of AMI can reduce QRSS, QRSS can be used as a reference for early thrombolytic recanalization.